NKTX: Nkarta, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 105.85
Enterprise Value ($M) 48.89
Book Value ($M) 430.87
Book Value / Share 6.11
Price / Book 0.25
NCAV ($M) 188.99
NCAV / Share 2.68
Price / NCAV 0.56

Profitability (mra)
Return on Invested Capital (ROIC) -0.21
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.40

Liquidity (mrq)
Quick Ratio 12.91
Current Ratio 12.91

Balance Sheet (mrq) ($M)
Current Assets 290.15
Assets 532.03
Liabilities 101.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Commodore Capital Lp 0.50 -92.45
02-12 13G/A Adage Capital Partners Gp, L.l.c. 0.00 -100.00
02-12 13D/A LSP 6 Holding C.V. 4.00 0.00
01-27 13G Tang Capital Management Llc 9.90
12-13 13G Citadel Advisors Llc 5.40
11-14 13G/A Flynn James E 3.05 -36.62
11-12 13G/A Adage Capital Management, L.P. 5.10
11-08 13G BlackRock, Inc. 6.00 0.00
10-25 13G/A Boxer Capital Management, LLC 4.90
03-29 13D/A Samsara BioCapital, L.P. 5.40 31.38
03-29 13D/A Ra Capital Management, L.p. 18.90 76.81
03-28 13D/A Glaxosmithkline Plc 4.50 0.00
03-28 13D/A New Enterprise Associates 15, L.P. 5.10 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-21 192,217 635,927 30.23
2025-03-20 158,745 745,435 21.30
2025-03-19 176,221 961,455 18.33
2025-03-18 324,918 1,105,349 29.40
2025-03-17 231,148 903,304 25.59

(click for more detail)

Similar Companies
MYGN – Myriad Genetics, Inc. NBIX – Neurocrine Biosciences, Inc.
NEOG – Neogen Corporation NMRA – Neumora Therapeutics, Inc.
NUVL – Nuvalent, Inc.


Financial data and stock pages provided by
Fintel.io